FORT LAUDERDALE, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, announced a partnership with Hitachi Inspharma, a group of Hitachi Ltd. Under the terms of the partnership, the two companies will work together to provide life science clients in Japan with eClinical solutions, including TrialMaster® electronic data capture (EDC), Acuity Analytics (data visualization and risk-based monitoring) and other related products/services to help improve trial insight and data quality and integrity during clinical trials.
“We are excited to collaborate with OmniComm Systems to bring state-of-the-art technology and the best of eClinical solutions to customers in Japan, and to develop these services to meet customers’ high-grade requirements,” said Hitachi Inspharma President Yamada Naoaki.
With this agreement, Hitachi Inspharma expands its existing portfolio of information systems and applications to include eClinical solutions, and the company will provide sales and support services, including TrialMaster study build and Acuity study configuration, as well as hosting.
“Our partnership with Hitachi Inspharma is an important step forward in building OmniComm’s presence in Japan,” said Stephen Johnson, chief executive officer and president of OmniComm. “Adding Hitachi Inspharma’s experienced support staff to our own local experts will increase the robustness and localization of our after-sales services. TrialMaster study build services and the integration of OmniComm’s products with third-party eClinical solutions are other areas where Hitachi Inspharma will quickly show the value of its expertise by offering superior IT services to the life sciences industry. As a result, this partnership will increase easy access to OmniComm’s innovative products for customers in Japan.”
About Hitachi Inspharma
Established in February 2006, Hitachi Inspharma started operations as an IT solution company specializing in the pharmaceutical industry. Hitachi Inspharma seeks to offer the highest standard of system solution in every aspect of pharmaceutical activities, such as R&D, production and marketing, based on the technology, development ability and the collective strength of the Hitachi group. Hitachi Inspharma Ltd. operates as a group of Hitachi Ltd. For more information, visit www.hitachi-inspharma.co.jp/.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry, offering eClinical solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. For more information, visit www.omnicomm.com.
Contact Info
Kuno van der Post, Ph.D.
OmniComm Systems, Inc.
+1.954.473.1254
KvanderPost@omnicomm.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.